Privia Health Group, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Privia Health Group, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Privia Health Group, Inc. has recorded 270 reports. Market capitalisation: €2.6bn. The latest transaction was reported on 3 September 2026 (Attribution). Among the most active insiders: Sullivan William M. The full history is openly available.
Analyst consensus: bullish or bearish? Analysts rate Privia Health Group, Inc. Strong Buy (bullish), based on 18 analysts. Average price target: US$31.67.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,058 of 29,064 companies
FCF yld 6.2%
Earn yld 0.9%
EV/EBITDA 59.5x
ROE 4.3%
Gross mgn 9.9%
Net mgn 1.1%
Debt/EBITDA 0.2x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
All Executives270 Thresholds0 Prospectus0 Other0
Declarations 270 total
◆ Director · Executives · 1 Sept 2026
6,350 shares 0Common Stock, $0.01 par value per share SEC:0001759655-26-000076:0
▼ EVP & Chief Financial Officer · Executives · 9 Jul 2026
21,275 shares @ US$27.67 0.017% mcap 6.6% of flow Common Stock, par value $0.01 per share SEC:0001759655-26-000057:0
● Officer · Executives · 9 Jul 2026
21,275 shares @ US$27.6664 0.017% mcap 7.9% of flow Common SEC144:0001959173-26-005184
▼ EVP & Chief Financial Officer · Executives · 7 Jul 2026
600 shares @ US$27.57 0.0005% mcap 0.2% of flow Common Stock, par value $0.01 per share SEC:0001858396-26-000016:0
● Officer · Executives · 7 Jul 2026
600 shares @ US$27.565 0.0005% mcap 0.2% of flow Common SEC144:0001959173-26-005147
◇ Director · Executives · 2 Jul 2026
59,037 shares @ US$2.00 0.0034% mcap 1.7% of flow Common Stock, par value $0.01 per share SEC:0001401958-26-000010:0
▼ Director · Executives · 2 Jul 2026
59,037 shares @ US$27.33 0.047% mcap 23.2% of flow Common Stock, par value $0.01 per share SEC:0001401958-26-000010:1
◇ Director · Executives · 6 Jul 2026
53,722 shares @ US$2.00 0.0031% mcap 1.5% of flow Common Stock, par value $0.01 per share SEC:0001401958-26-000010:2
▼ Director · Executives · 6 Jul 2026
53,722 shares @ US$27.24 0.042% mcap 21.0% of flow Common Stock, par value $0.01 per share SEC:0001401958-26-000010:3
▼ EVP & Chief Financial Officer · Executives · 2 Jul 2026
24,734 shares @ US$27.50 0.020% mcap 8.8% of flow Common Stock, par value $0.01 per share SEC:0001858396-26-000014:0
● Officer · Executives · 2 Jul 2026
24,734 shares @ US$27.5001 0.019% mcap 9.9% of flow Common SEC144:0001959173-26-005071
● Officer · Executives · 26 Jun 2026
17,196 shares @ US$25.1824 0.012% mcap 5.2% of flow Common SEC144:0001959173-26-004929
◆ Director · Executives · 20 May 2026
8,463 shares 0Common Stock, $0.01 par value per share SEC:0001759655-26-000043:0
◆ Director · Executives · 20 May 2026
8,463 shares 0Common Stock, $0.01 par value per share SEC:0001759655-26-000042:0
▼ Chief Executive Officer · Executives · 11 May 2026
105,439 shares @ US$22.55 0.070% mcap 35.3% of flow Common Stock, $0.01 par value per share SEC:0001759655-26-000030:0
▼ EVP & Chief Financial Officer · Executives · 11 May 2026
3,385 shares @ US$22.60 0.0022% mcap 2.3% of flow Common Stock, par value $0.01 per share SEC:0001858396-26-000011:0
▼ EVP & Chief Financial Officer · Executives · 2 Apr 2026
5,566 shares @ US$20.85 0.0035% mcap 3.6% of flow Common Stock, par value $0.01 per share SEC:0001858396-26-000006:0
▼ Chief Executive Officer · Executives · 16 Mar 2026
26,509 shares @ US$22.11 7.0% of flow Common Stock, $0.01 par value per share SEC:0001858398-26-000006:0
▼ EVP & Chief Financial Officer · Executives · 16 Mar 2026
6,391 shares @ US$22.11 1.9% of flow Common Stock, par value $0.01 per share SEC:0001759655-26-000019:0
▼ Chief Executive Officer · Executives · 12 Mar 2026
26,763 shares @ US$21.90 6.5% of flow Common Stock, $0.01 par value per share SEC:0001858398-26-000004:0
▼ EVP & Chief Financial Officer · Executives · 12 Mar 2026
6,453 shares @ US$21.90 1.8% of flow Common Stock, par value $0.01 per share SEC:0001858396-26-000003:0
◆ EVP & General Counsel · Executives · 10 Mar 2026
28,268 shares 0Common Stock, $0.01 par value per share SEC:0002009323-26-000002:0
◆ EVP & Chief Financial Officer · Executives · 10 Mar 2026
35,335 shares 0Common Stock, par value $0.01 per share SEC:0001858396-26-000001:0
▼ Chief Executive Officer · Executives · 10 Mar 2026
21,097 shares @ US$22.71 5.0% of flow Common Stock, $0.01 par value per share SEC:0001858398-26-000002:0
▼ EVP & General Counsel · Executives · 6 Mar 2026
4,394 shares @ US$23.15 60.5% of flow Common Stock, $0.01 par value per share SEC:0001759655-26-000016:0
25 of 270 declarations
Load more (245 remaining) 关于 Privia Health Group, Inc. Privia Health Group, Inc.(股票代码:PRVA)是一家在美国纳斯达克市场上市的美国医疗保健公司。Privia 最好被理解为一个医生赋能平台,而非传统的医疗服务提供者或保险公司。其模式旨在帮助医生、医疗团体、健康计划和医疗系统提供更协调的护理、改善患者预后并降低整体医疗成本。该公司结合了区域医疗团体、医生主导的治理、管理服务组织以及一个支持人口健康、工作流程效率、护理差距管理和基于价值的护理执行的云端技术和分析堆栈。
Privia 成立于 2007 年,已从一个区域性医生平台发展成为一个全国性组织。其总部位于弗吉尼亚州阿灵顿,这使得该公司靠近美国主要的医疗保健政策、支付方和提供者网络。随着时间的推移,Privia 已将其业务从大西洋中部地区扩展到多个美国市场,包括弗吉尼亚州、马里兰州和华盛顿特区,以及佐治亚州、德克萨斯州、佛罗里达州、田纳西州、加利福尼亚州、蒙大拿州、俄亥俄州、北卡罗来纳州、康涅狄格州、华盛顿州、南卡罗来纳州和印第安纳州。这种地域扩张反映了其审慎的市场逐个推出策略,并根据每个州的监管和支付方环境调整当地运营结构。
公司的核心业务线围绕组织初级保健和多专科医生诊所、提供诊所管理支持以及促成参与基于价值的护理安排。通过当地 MSO 和相关医疗团体,Privia 支持提供者合同、报销谈判、患者记录管理和人口健康计划。它还参与责任医疗组织结构,包括 Privia 拥有的 ACO,使公司能够通过基于绩效的报销模式获利,并深化其在 Medicare 和商业基于价值的护理中的参与。实际上,Privia 的竞争优势在于为医生提供规模、运营基础设施和技术,同时保持高度的临床自主权。
在竞争方面,Privia 处于美国医疗保健服务一个有吸引力但要求严格的细分市场。它在基于价值的护理领域争夺医生合作、支付方关系和市场份额,在该领域,执行质量和当地医生的信任与技术同样重要。其平台方法使其与纯粹的行政外包模式区分开来,而其医生主导的结构有助于支持留存和诊所参与度。
最近的发展强化了投资理由。2025 年,Privia 报告了强劲的财务和运营势头,包括收入增长、运营利润改善以及已实施提供者和归属生命的持续增加。该公司还在 2025 年 9 月宣布了一项协议,收购 Evolent Health 的 ACO 业务,扩大其基于价值的护理足迹,并增加商业、Medicare、Medicare Advantage 和 Medicaid 安排中的归属生命。对于投资者而言,PRVA 是一家在美国纳斯达克上市的医疗保健技术和服务复合型公司,受益于向协调护理、风险承担提供者模式和医生主导网络整合的长期转变。